HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alejandro B Balazs Selected Research

Neonatal herpes

12/2022Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alejandro B Balazs Research Topics

Disease

30Infections
03/2024 - 08/2011
15COVID-19
03/2024 - 10/2020
5HIV Infections (HIV Infection)
01/2023 - 08/2011
4Neoplasms (Cancer)
01/2023 - 01/2022
3Breakthrough Infections
04/2023 - 12/2022
3Communicable Diseases (Infectious Diseases)
01/2022 - 08/2015
3Human Influenza (Influenza)
01/2020 - 07/2013
2Persistent Infection
01/2023 - 01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Rheumatoid Arthritis
01/2023
1Neonatal herpes
12/2022
1COVID-19 related pediatric multisystem inflammatory disease
11/2022
1Malaria
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Virus Diseases (Viral Diseases)
01/2020
1Vesicular Stomatitis
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2015
1Disease Progression
09/2014
1Myeloid Leukemia (Leukemia, Myelocytic)
08/2010
1Myeloproliferative Disorders (Myeloproliferative Disorder)
08/2010
1Aneuploidy (Aneuploid)
04/2008

Drug/Important Bio-Agent (IBA)

21VaccinesIBA
04/2023 - 03/2014
9Neutralizing AntibodiesIBA
03/2024 - 09/2014
9Broadly Neutralizing AntibodiesIBA
01/2023 - 01/2013
9AntibodiesIBA
01/2022 - 08/2014
7Proteins (Proteins, Gene)FDA Link
03/2024 - 08/2014
7Messenger RNA (mRNA)IBA
02/2023 - 11/2021
7BNT162 VaccineIBA
02/2023 - 10/2021
6COVID-19 VaccinesIBA
03/2024 - 01/2022
4mRNA VaccinesIBA
02/2023 - 12/2022
4Glycoproteins (Glycoprotein)IBA
12/2022 - 01/2020
3AIDS VaccinesIBA
01/2020 - 01/2017
2Combined VaccinesIBA
03/2024 - 04/2023
2N-(2-cyanoethylene)urea (BA 1)IBA
01/2023 - 01/2023
2Interferon Type IIBA
01/2023 - 01/2022
2Immunoglobulin G (IgG)IBA
01/2023 - 01/2022
22019-nCoV Vaccine mRNA-1273IBA
11/2022 - 01/2022
2Monoclonal AntibodiesIBA
01/2021 - 08/2015
1Viral RNAIBA
03/2024
1SARS-CoV-2 spike proteinIBA
02/2023
1Interleukin-2 (IL2)IBA
01/2023
1Antiviral Agents (Antivirals)IBA
12/2022
1Immunoglobulin A (IgA)IBA
01/2022
1Ad26COVS1IBA
01/2022
1Nucleic AcidsIBA
01/2021
1EpitopesIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1CytokinesIBA
01/2021
1CIS43LSIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2020
1AntigensIBA
01/2020
1Polysaccharides (Glycans)IBA
01/2020
1Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseIBA
01/2020
1HIV AntibodiesIBA
09/2019
1Immunoglobulins (Immunoglobulin)IBA
12/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2014
1efavirenz (Sustiva)FDA Link
08/2011
1Tenofovir (Viread)FDA Link
08/2011
1MicroRNAs (MicroRNA)IBA
08/2010
1Small Interfering RNA (siRNA)IBA
04/2008

Therapy/Procedure

5Home Nursing (Nursing, Home)
03/2024 - 01/2022
4Therapeutics
12/2022 - 08/2011
1Radiotherapy
01/2022
1Long-Term Care
11/2021
1Aftercare (After-Treatment)
08/2015